Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Microglia derived from human induced pluripotent stem cells are regulated by osteopontin, an endogenous extracellular matrix protein maintaining immune homeostasis.

Frontiers in neuroscience·2026

Same author

Phenotype, Severity, and Therapy of Patients With LRP4 Antibody-Associated Myasthenia Gravis in the German Myasthenia Gravis Registry.

Neurology·2026

Same author

Non-ICANS neurotoxicity after BCMA-directed CAR-T therapy: Clinical spectrum, outcomes, and a framework for neurology-oncology co-management.

HemaSphere·2026

Same author

Case Report: B-cell-targeted therapy with ofatumumab achieves remission in refractory panuveitis and coexisting multiple sclerosis.

Frontiers in neurology·2026

Same author

Multicentric prognostic observational study on biomarker profile in immunotherapy-naïve patients with highly active generalized myasthenia gravis (PROGNO-MG): a study protocol.

Neurological research and practice·2026

Same author

ActIIR inhibition improves motor outcome and preserves muscle fibers after experimental autoimmune neuritis.

Acta neuropathologica communications·2026

Search research articles

Related Experiment Video

Updated: Feb 9, 2026

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research

Published on: August 4, 2023

[Myasthenic Crisis].

Henning R Stetefeld¹, Michael Schroeter¹

¹Klinik und Poliklinik für Neurologie, Uniklinik Köln, Köln, Deutschland.

Fortschritte Der Neurologie-Psychiatrie

|May 30, 2018

Summary

This summary is machine-generated.

Recognizing red flags in myasthenia gravis exacerbation can prevent a myasthenic crisis. Intensive care unit management involves specific therapies and addressing complications like infections and delirium.

More Related Videos

Inter-Brain Synchrony in Open-Ended Collaborative Learning: An fNIRS-Hyperscanning Study

Inter-Brain Synchrony in Open-Ended Collaborative Learning: An fNIRS-Hyperscanning Study

Published on: July 21, 2021

Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line

Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line

Published on: September 13, 2024

Related Experiment Videos

Last Updated: Feb 9, 2026

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research

Author Spotlight: Biological Standardization to Ensure Reproducibility and Harmonization in Research

Published on: August 4, 2023

Inter-Brain Synchrony in Open-Ended Collaborative Learning: An fNIRS-Hyperscanning Study

Inter-Brain Synchrony in Open-Ended Collaborative Learning: An fNIRS-Hyperscanning Study

Published on: July 21, 2021

Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line

Author Spotlight: Minimally Invasive Relief for Occipital Neuralgia at the Nuchal Line

Published on: September 13, 2024

Area of Science:

Neurology
Critical Care Medicine

Background:

Myasthenic crisis is a severe, life-threatening manifestation of myasthenia gravis.
It necessitates intensive care unit (ICU) admission due to severe dysphagia and respiratory insufficiency.

Purpose of the Study:

To review red flags indicating myasthenia gravis exacerbation and crisis.
To outline a structured approach for managing myasthenic crisis in the ICU.

Main Methods:

Review of literature on myasthenic crisis and exacerbation.
Discussion of diagnostic considerations, including differential diagnosis of bulbar symptoms.

Main Results:

Identification of key therapeutic strategies: acetylcholinesterase inhibitors, plasmapheresis, immunoadsorption, IVIg, early steroids, azathioprine, and rituximab.
Emphasis on ICU-specific management: structured weaning, comorbidity treatment, infection control, dysphagia management, and delirium prevention.

Conclusions:

Timely recognition of exacerbation can prevent crisis.
Comprehensive ICU management is crucial for optimizing outcomes in myasthenic crisis.